A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Condition:   BRAF V600 Colorectal Cancer Interventions:   Drug: Dabrafenib;   Drug: LTT462;   Drug: Trametinib;   Drug: LXH254;   Drug: TNO155;   Biological: Spartalizumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials